Algorithm of Examination and Management of Patients in the Detection of Fibroadenomas of the Breast
https://doi.org/10.52560/2713-0118-2021-3-31-40
Abstract
The article is devoted to the determination of the examination algorithm and management tactics for patients with various types of breast fibroadenomas based on a review of foreign literature and our own clinical experience.
About the Authors
O. O. Manyilova
City Clinical Hospital named after V. M. Buyanov, Moscow Healthcare Department
Russian Federation
Russian Federation
Manu’lova Olga Olegovna, Ph. D. Med., Chief of Radiologist of the Department of Radiology
26, ul. Bakinskaya, Moscow, 115516
+7 (926) 220-37-25
I. A. Solntseva
Federal State Budgetary Educational Institution of Higher Education «North-Western State Medical University named after I. I. Mechnikov», Ministry of Health of Russia; LLC «Mart»
Russian Federation
Russian Federation
Solntseva Irina, Ph. D. Med., Associate Professor of the Department of Radiology and Radiotherapy; head of Ultrasound Diagnostics Department «Мart»
41, ul. Kirochnaya, St. Petersburg, 191015
+7 (921) 934-30-91
References
1. Vysotskaya I. V., Letyagin V. P., Cherenkov V. G., Bublikov I. D., Laktionov K. P. Clinical guidelines of the Russian society of oncomammologists for the prevention of breast cancer, differential diagnosis, treatment of precancerous and benign breast diseases. Tumors of female reproductive system. 2016. No. 12 (3). P. 43–52 (in Russian).
2. Garifullova Yu. V. Radiation methods for the diagnosis of benign diseases of the breast. Practical Medicine. 2017. No. 7 (108). P 51–56. (in Russian).
3. Kaprin A. D., Rozhkova N. I. Mammology: national leadership. Moscow: GEOTARMEDIA, 2016. 496 p. (in Russian).
4. Afanasiou A., Aubert E., Vincent Salomon A., Tardivon A. Complex cystic breast masses on ultrasound. Inter. Imag. Diagn. 2014. No. 95. P.169–179.
5. Cuzick J., Sestak I., Thorat M. A. The effect of preventive therapy on breast cancer risk in women with benign breast disease. Chest. 2015. No. 24 (2). P. 51–55.
6. El-Wakil H., Umpleby H. S. A systematic review of fibroadenoma as a risk factor for breast cancer. Chest. 2003. No. 12. P. 302–307.
7. Hughes L. E., Mansel R. E., Webster D. J. Aberrations of normal development and involution (ANDI): a new look at the pathogenesis and nomenclature of benign breast diseases. Lancet. 1987. No. 2. P. 1316–1319.
8. Krings G., Bean G. R., Chen Yu. Y. Fibroepithelial lesions. WHO spectrum. Semin Diagn. Pathol. 2017. No. 34. P. 438–452.
9. Nassar A., Visscher D. W., Degnim A. C., Frank R. D., Vierkant R. A., Frost M., Radisky D. C., Vachon C. M., Kraft R. A., Hartmann L. C., Ghosh K. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study. Breast Cancer Res. Treat. 2015. No. 153 (2). P. 397–405. DOI: 10.1007/s10549-015-3535-8.
10. Stachs A., Stubert J., Reimer T., Hartmann S. Benign breast disease in women. Dtsch. Arztebl. Int. 2019. No. 116 (33–34). P. 565–574. DOI: 10.3238/arztebl.2019.0565.
11. WHO Breast tumors. Classification of Tumors. 2019. V. 2. 368 p.
Review
For citations:
Manyilova O.O., Solntseva I.A. Algorithm of Examination and Management of Patients in the Detection of Fibroadenomas of the Breast. Radiology - Practice. 2021;(3):31-40. (In Russ.) https://doi.org/10.52560/2713-0118-2021-3-31-40
Views:
795
Email this article 